IRF4 controls the positioning of mature B cells in the lymphoid microenvironments by regulating NOTCH2 expression and activity

Journal of Experimental Medicine

Volumn 210, Issue 13, 2013, Pages 2887-2902

  Simonetti, Giorgia ^a   Carette, Amanda ^a   Silva, Kathryn ^a   Wang, Haowei ^c   De Silva, Nilushi S ^a   Heise, Nicole ^a   Siebel, Christian W ^e   Shlomchik, Mark J ^c,d   Klein, Ulf ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CRE RECOMBINASE; ENHANCED GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN M; INTERFERON REGULATORY FACTOR 4; NOTCH2 RECEPTOR; TAMOXIFEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENE EXPRESSION; GENOTYPE; GERMINAL CENTER; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; LYMPHOID CELL; MARGINAL ZONE LYMPHOMA; MICROENVIRONMENT; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION REGULATION; GERMINAL CENTER; GREEN FLUORESCENT PROTEINS; INTERFERON REGULATORY FACTORS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; PHENOTYPE; RECEPTOR, NOTCH2; SIGNAL TRANSDUCTION; SPLEEN;

EID: 84890808213     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20131026     Document Type: Article

References (62)

1. Aifantis, I., E. Raetz, and S. Buonamici. 2008. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat. Rev. Immunol. 8:380-390. http://dx.doi.org/10.1038/nri2304
2. Arnon, T.I., R.M. Horton, I.L. Grigorova, and J.G. Cyster. 2013. Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress. Nature. 493:684-688.
3. Brown, J.R., M. Hanna, B. Tesar, N. Pochet, A. Vartanov, S.M. Fernandes, L. Werner, M. Ash, C.A. Roden, L. MacConaill, et al. 2012. Germline copy number variation associated with Mendelian inheritance of CLL in two families. Leukemia. 26:1710-1713. http://dx.doi.org/10.1038/leu.2012.33
4. Burger, J.A., P. Ghia, A. Rosenwald, and F. Caligaris-Cappio. 2009. The microenvironment in mature B-cell malignancies: a target for new treatment strategies. Blood. 114:3367-3375. http://dx.doi.org/10.1182/blood-2009-06-225326
5. Cattoretti, G., C. Angelin-Duclos, R. Shaknovich, H. Zhou, D. Wang, and B. Alobeid. 2005. PRDM1/Blimp-1 is expressed in human B-lymphocytes committed to the plasma cell lineage. J. Pathol. 206:76-86. http://dx.doi.org/10.1002/path.1752
6. Cattoretti, G., R. Shaknovich, P.M. Smith, H.M. Jäck, V.V. Murty, and B. Alobeid. 2006. Stages of germinal center transit are defined by B cell transcription factor coexpression and relative abundance. J. Immunol. 177:6930-6939.
7. Cayrol, R., K. Wosik, J.L. Berard, A. Dodelet-Devillers, I. Ifergan, H. Kebir, A.S. Haqqani, K. Kreymborg, S. Krug, R. Moumdjian, et al. 2008. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system. Nat. Immunol. 9:137-145. http://dx.doi. org/10.1038/ni1551
8. Cinamon, G., M. Matloubian, M.J. Lesneski, Y. Xu, C. Low, T. Lu, R.L. Proia, and J.G. Cyster. 2004. Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat. Immunol. 5:713-720. http://dx.doi.org/10.1038/ni1083
9. Cinamon, G., M.A. Zachariah, O.M. Lam, F.W. Foss Jr., and J.G. Cyster. 2008. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol. 9:54-62. http://dx.doi.org/10.1038/ni1542
10. Crowther-Swanepoel, D., P. Broderick, Y. Ma, L. Robertson, A.M. Pittman, A. Price, P. Twiss, J. Vijayakrishnan, M. Qureshi, M.J. Dyer, et al. 2010. Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locus. Hum. Mol. Genet. 19:1840-1845. http://dx.doi.org/10.1093/hmg/ddq044
11. Cyster, J.G., and S.R. Schwab. 2012. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30:69-94. http://dx.doi.org/10.1146/annurev-immunol-020711-075011
12. De Silva, N.S., G. Simonetti, N. Heise, and U. Klein. 2012. The diverse roles of IRF4 in late germinal center B-cell differentiation. Immunol. Rev. 247:73-92. http://dx.doi.org/10.1111/j.1600-065X.2012.01113.x
13. Di Bernardo, M.C., D. Crowther-Swanepoel, P. Broderick, E. Webb, G. Sellick, R. Wild, K. Sullivan, J. Vijayakrishnan, Y. Wang, A.M. Pittman, et al. 2008. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat. Genet. 40:1204-1210. http://dx.doi.org/10.1038/ng.219
14. Dominguez-Sola, D., C.Y. Ying, C. Grandori, L. Ruggiero, B. Chen, M. Li, D.A. Galloway, W. Gu, J. Gautier, and R. Dalla-Favera. 2007. Non-transcriptional control of DNA replication by c-Myc. Nature. 448:445-451. http://dx.doi.org/10.1038/nature05953
15. Fabbri, G., S. Rasi, D. Rossi, V. Trifonov, H. Khiabanian, J. Ma, A. Grunn, M. Fangazio, D. Capello, S. Monti, et al. 2011. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J. Exp. Med. 208:1389-1401. http://dx.doi.org/10.1084/jem.20110921
16. Falini, B., M. Fizzotti, A. Pucciarini, B. Bigerna, T. Marafioti, M. Gambacorta, R. Pacini, C. Alunni, L. Natali-Tanci, B. Ugolini, et al. 2000. A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood. 95:2084-2092.
17. Ghia, P., N. Chiorazzi, and K. Stamatopoulos. 2008. Microenvironmental influences in chronic lymphocytic leukaemia: the role of antigen stimulation. J. Intern. Med. 264:549-562. http://dx.doi.org/10.1111/j.1365-2796.2008.02030.x
18. Guy, C.S., K.M. Vignali, J. Temirov, M.L. Bettini, A.E. Overacre, M. Smeltzer, H. Zhang, J.B. Huppa, Y.H. Tsai, C. Lobry, et al. 2013. Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nat. Immunol. 14:262-270. http://dx.doi.org/10.1038/ni.2538
19. Hampel, F., S. Ehrenberg, C. Hojer, A. Draeseke, G. Marschall-Schröter, R. Kühn, B. Mack, O. Gires, C.J. Vahl, M. Schmidt-Supprian, et al. 2011. CD19-independent instruction of murine marginal zone B-cell development by constitutive Notch2 signaling. Blood. 118:6321-6331. http://dx.doi.org/10.1182/blood-2010-12-325944
20. Hoellenriegel, J., S.A. Meadows, M. Sivina, W.G. Wierda, H. Kantarjian, M.J. Keating, N. Giese, S. O'Brien, A. Yu, L.L. Miller, et al. 2011. The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia. Blood. 118:3603-3612. http://dx.doi.org/10.1182/blood-2011-05-352492
21. Holl, E.K., B.P. O'Connor, T.M. Holl, K.E. Roney, A.G. Zimmermann, S. Jha, G. Kelsoe, and J.P. Ting. 2011. Plexin-D1 is a novel regulator of germinal centers and humoral immune responses. J. Immunol. 186:5603-5611. http://dx.doi.org/10.4049/jimmunol.1003464
22. Hozumi, K., N. Negishi, D. Suzuki, N. Abe, Y. Sotomaru, N. Tamaoki, C. Mailhos, D. Ish-Horowicz, S. Habu, and M.J. Owen. 2004. Delta-like 1 is necessary for the generation of marginal zone B cells but not T cells in vivo. Nat. Immunol. 5:638-644. http://dx.doi.org/10.1038/ni1075
23. Khalil, A.M., J.C. Cambier, and M.J. Shlomchik. 2012. B cell receptor signal transduction in the GC is short-circuited by high phosphatase activity. Science. 336:1178-1181. http://dx.doi.org/10.1126/science.1213368
24. Kiel, M.J., T. Velusamy, B.L. Betz, L. Zhao, H.G. Weigelin, M.Y. Chiang, D.R. Huebner-Chan, N.G. Bailey, D.T. Yang, G. Bhagat, et al. 2012. Wholegenome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J. Exp. Med. 209:1553-1565. http://dx.doi.org/10.1084/jem.20120910
25. Kin, N.W., D.M. Crawford, J. Liu, T.W. Behrens, and J.F. Kearney. 2008. DNA microarray gene expression profile of marginal zone versus follicular B cells and idiotype positive marginal zone B cells before and after immunization with Streptococcus pneumoniae. J. Immunol. 180:6663-6674.
26. Klein, U., Y. Tu, G.A. Stolovitzky, M. Mattioli, G. Cattoretti, H. Husson, A. Freedman, G. Inghirami, L. Cro, L. Baldini, et al. 2001. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J. Exp. Med. 194:1625-1638. http://dx.doi.org/10.1084/jem.194.11.1625
27. Klein, U., S. Casola, G. Cattoretti, Q. Shen, M. Lia, T. Mo, T. Ludwig, K. Rajewsky, and R. Dalla-Favera. 2006. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat. Immunol. 7:773-782. http://dx.doi.org/10.1038/ni1357
28. Lu, R., K.L. Medina, D.W. Lancki, and H. Singh. 2003. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development. Genes Dev. 17:1703-1708. http://dx.doi.org/10.1101/gad.1104803
29. Lu, T.T., and J.G. Cyster. 2002. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science. 297:409-412. http://dx.doi.org/10.1126/science.1071632
30. Martin, F., and J.F. Kearney. 2000. B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a "natural immune memory". Immunol. Rev. 175:70-79. http://dx.doi.org/10.1111/j.1600-065X.2000.imr017515.x
31. Mittrücker, H.W., T. Matsuyama, A. Grossman, T.M. Kündig, J. Potter, A. Shahinian, A. Wakeham, B. Patterson, P.S. Ohashi, and T.W. Mak. 1997. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science. 275:540-543. http://dx.doi.org/10.1126/science.275.5299.540
32. Moriyama, Y., C. Sekine, A. Koyanagi, N. Koyama, H. Ogata, S. Chiba, S. Hirose, K. Okumura, and H. Yagita. 2008. Delta-like 1 is essential for the maintenance of marginal zone B cells in normal mice but not in autoimmune mice. Int. Immunol. 20:763-773. http://dx.doi.org/10.1093/intimm/dxn034
33. Muppidi, J.R., T.I. Arnon, Y. Bronevetsky, N. Veerapen, M. Tanaka, G.S. Besra, and J.G. Cyster. 2011. Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone. J. Exp. Med. 208:1941-1948. http://dx.doi.org/10.1084/jem.20111083
34. Nakamura, M., H. Yagi, S. Kayaba, T. Ishii, T. Gotoh, S. Ohtsu, and T. Itoh. 1996. Death of germinal center B cells without DNA fragmentation. Eur. J. Immunol. 26:1211-1216. http://dx.doi.org/10.1002/eji.1830260604
35. Nakamura, M., H. Yagi, T. Ishii, S. Kayaba, H. Soga, T. Gotoh, S. Ohtsu, M. Ogata, and T. Itoh. 1997. DNA fragmentation is not the primary event in glucocorticoid-induced thymocyte death in vivo. Eur. J. Immunol. 27:999-1004. http://dx.doi.org/10.1002/eji.1830270429
36. Nie, L., M. Xu, A. Vladimirova, and X.H. Sun. 2003. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J. 22:5780-5792. http://dx.doi.org/10.1093/emboj/cdg567
37. Ochiai, K., M. Maienschein-Cline, G. Simonetti, J. Chen, R. Rosenthal, R. Brink, A.S. Chong, U. Klein, A.R. Dinner, H. Singh, and R. Sciammas. 2013. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity. 38:918-929. http://dx.doi.org/10.1016/j.immuni.2013.04.009
38. Pillai, S., and A. Cariappa. 2009. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 9:767-777. http://dx.doi.org/10.1038/nri2656
39. Pillai, S., A. Cariappa, and S.T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23:161-196. http://dx.doi.org/10.1146/annurev.immunol.23.021704.115728
40. Ponader, S., S.S. Chen, J.J. Buggy, K. Balakrishnan, V. Gandhi, W.G. Wierda, M.J. Keating, S. O'Brien, N. Chiorazzi, and J.A. Burger. 2012. The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo. Blood. 119:1182-1189. http://dx.doi.org/10.1182/blood-2011-10-386417
41. Puente, X.S., M. Pinyol, V. Quesada, L. Conde, G.R. Ordóñez, N. Villamor, G. Escaramis, P. Jares, S. Beà, M. González-Díaz, et al. 2011. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 475:101-105. http://dx.doi.org/10.1038/nature10113
42. Rosati, E., R. Sabatini, G. Rampino, A. Tabilio, M. Di Ianni, K. Fettucciari, A. Bartoli, S. Coaccioli, I. Screpanti, and P. Marconi. 2009. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood. 113:856-865. http://dx.doi.org/10.1182/blood-2008-02-139725
43. Rosati, E., R. Sabatini, F. De Falco, B. Del Papa, F. Falzetti, M. Di Ianni, L. Cavalli, K. Fettucciari, A. Bartoli, I. Screpanti, and P. Marconi. 2013. γ-Secretase inhibitor I induces apoptosis in chronic lymphocytic leukemia cells by proteasome inhibition, endoplasmic reticulum stress increase and notch down-regulation. Int. J. Cancer. 132:1940-1953. http://dx.doi.org/10.1002/ijc.27863
44. Rossi, D., V. Trifonov, M. Fangazio, A. Bruscaggin, S. Rasi, V. Spina, S. Monti, T. Vaisitti, F. Arruga, R. Famà, et al. 2012. The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development. J. Exp. Med. 209:1537-1551. http://dx.doi.org/10.1084/jem.20120904
45. Saito, M., J. Gao, K. Basso, Y. Kitagawa, P.M. Smith, G. Bhagat, A. Pernis, L. Pasqualucci, and R. Dalla-Favera. 2007. A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma. Cancer Cell. 12:280-292. http://dx.doi.org/10.1016/j.ccr.2007.08.011
46. Saito, T., S. Chiba, M. Ichikawa, A. Kunisato, T. Asai, K. Shimizu, T. Yamaguchi, G. Yamamoto, S. Seo, K. Kumano, et al. 2003. Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development. Immunity. 18:675-685. http://dx.doi.org/10.1016/S1074-7613(03)00111-0
47. Sciammas, R., A.L. Shaffer, J.H. Schatz, H. Zhao, L.M. Staudt, and H. Singh. 2006. Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation. Immunity. 25:225-236. http://dx.doi.org/10.1016/j.immuni.2006.07.009
48. Sciammas, R., Y. Li, A. Warmflash, Y. Song, A.R. Dinner, and H. Singh. 2011. An incoherent regulatory network architecture that orchestrates B cell in response to antigen signaling. Mol. Syst. Biol. 7:495. http://dx.doi.org/10.1038/msb.2011.25
49. Shaffer, A.L., N.C. Emre, P.B. Romesser, and L.M. Staudt. 2009. IRF4: Immunity. Malignancy! Therapy? Clin. Cancer Res. 15:2954-2961. http://dx.doi.org/10.1158/1078-0432.CCR-08-1845
50. Shaffer, A.L. III, R.M. Young, and L.M. Staudt. 2012. Pathogenesis of human B cell lymphomas. Annu. Rev. Immunol. 30:565-610. http://dx.doi.org/10.1146/annurev-immunol-020711-075027
51. Shi, G.X., K. Harrison, G.L. Wilson, C. Moratz, and J.H. Kehrl. 2002. RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13. J. Immunol. 169:2507-2515.
52. Shukla, V., S. Ma, R.R. Hardy, S.S. Joshi, and R. Lu. 2013. A role for IRF4 in the development of CLL. Blood. 122:2848-2855. http://dx.doi.org/10.1182/blood-2013-03-492769
53. Stevenson, F.K., and F. Caligaris-Cappio. 2004. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood. 103:4389-4395. http://dx.doi.org/10.1182/blood-2003-12-4312
54. Tan, J.B., K. Xu, K. Cretegny, I. Visan, J.S. Yuan, S.E. Egan, and C.J. Guidos. 2009. Lunatic and manic fringe cooperatively enhance marginal zone B cell precursor competition for delta-like 1 in splenic endothelial niches. Immunity. 30:254-263. http://dx.doi.org/10.1016/j.immuni.2008.12.016
55. Tanigaki, K., H. Han, N. Yamamoto, K. Tashiro, M. Ikegawa, K. Kuroda, A. Suzuki, T. Nakano, and T. Honjo. 2002. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3:443-450. http://dx.doi.org/10.1038/ni793
56. Thomas, M., M. Calamito, B. Srivastava, I. Maillard, W.S. Pear, and D. Allman. 2007. Notch activity synergizes with B-cell-receptor and CD40 signaling to enhance B-cell activation. Blood. 109:3342-3350. http://dx.doi.org/10.1182/blood-2006-09-046698
57. Tran, I.T., A.R. Sandy, A.J. Carulli, C. Ebens, J. Chung, G.T. Shan, V. Radojcic, A. Friedman, T. Gridley, A. Shelton, et al. 2013. Blockade of individual Notch ligands and receptors controls graft-versus-host disease. J. Clin. Invest. 123:1590-1604. http://dx.doi.org/10.1172/JCI65477
58. Tsuboi, K., S. Iida, H. Inagaki, M. Kato, Y. Hayami, I. Hanamura, K. Miura, S. Harada, M. Kikuchi, H. Komatsu, et al. 2000. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia. 14:449-456. http://dx.doi.org/10.1038/sj.leu.2401696
59. Wang, H., N. Beaty, S. Chen, C.F. Qi, M. Masiuk, D.M. Shin, and H.C. Morse III. 2012. The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12. Blood. 119:465-468. http://dx.doi.org/10.1182/blood-2011-03-343608
60. Welcker, M., and B.E. Clurman. 2008. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer. 8:83-93. http://dx.doi.org/10.1038/nrc2290
61. Wu, Y., C. Cain-Hom, L. Choy, T.J. Hagenbeek, G.P. de Leon, Y. Chen, D. Finkle, R. Venook, X. Wu, J. Ridgway, et al. 2010. Therapeutic antibody targeting of individual Notch receptors. Nature. 464:1052-1057. http://dx.doi.org/10.1038/nature08878
62. Ye, B.H., G. Cattoretti, Q. Shen, J. Zhang, N. Hawe, R. de Waard, C. Leung, M. Nouri-Shirazi, A. Orazi, R.S. Chaganti, et al. 1997. The BCL-6 protooncogene controls germinal-centre formation and Th2-type inflammation. Nat. Genet. 16:161-170. http://dx.doi.org/10.1038/ng0697-161